alternatives to semaglutide for weight loss and Loss: What You Need Know FDA Approves Oral Semaglutide as

Micro-Injury Induces Hair Regeneration and Vitiligo Repigmentation Through Wnt/beta-Catenin Pathway

doi: 10.3389/fendo.2024.1358404 Received 19 December 2023 Accepted 15 February 2024 Published 05 March 2024 Volume 15 - 2024 Edited by Chen Liu, University of Texas Southwestern Medical Center, United States Reviewed by Surbhi Gahlot, University of Texas Southwestern Medical Center, United States Carlos Manuel Zapata-Martn del Campo, National Institute of Cardiology Ignacio Chavez, Mexico Updates Copyright 2024 Raij and Raij

Adverse event summary FDA has received reports of dosing errors involving compounded semaglutide injectable products dispensed in multiple-dose vials

There has been an increasing amount of evidence suggesting that CAP can affect the composition, abundance, and function of the gut microbiota